
Sign up to save your podcasts
Or
Donna H. Ryan, MD, Professor Emerita at Pennington Biomedical Research Center, joins the podcast to discuss obesity therapies and the results of the SELECT trial.
TIMI turning 40 | Exciting Storylines in 2024 | A Graveyard of Weight Loss Drugs | Breakthrough of Semaglutide (Ozempic/Weygovy/Rybelsus) | SELECT Trial | Obesity as a Disease | Nick and David’s Podcast Resolutions
Donna H. Ryan, MD, Professor Emerita at Pennington Biomedical Research Center, joins the podcast to discuss obesity therapies and the results of the SELECT trial.
TIMI turning 40 | Exciting Storylines in 2024 | A Graveyard of Weight Loss Drugs | Breakthrough of Semaglutide (Ozempic/Weygovy/Rybelsus) | SELECT Trial | Obesity as a Disease | Nick and David’s Podcast Resolutions